Author： Yen Yun Margolin Kim Doroshow James Fishman Mayer Johnson Bonny Clairmont Caroline Sullivan Dan Sznol Mario
Publisher： Springer Publishing Company
ISSN： 0344-5704
Source： Cancer Chemotherapy and Pharmacology, Vol.54, Iss.4, 2004-10, pp. : 331-342
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
By Choi Brian Alberti Dona Schelman William Kolesar Jill Thomas James Marnocha Rebecca Eickhoff Jens Ivy S. Wilding George Holen Kyle
Cancer Chemotherapy and Pharmacology, Vol. 66, Iss. 5, 2010-10 ,pp. :
Access to resources
Recommend
A phase I trial of gemcitabine in combination with patupilone in patients with advanced solid tumors
By Schelman William Morgan-Meadows Sherry Bailey Howard Holen Kyle Thomas James Eickhoff Jens Brandon Heidi Oliver Kate Alberti Dona Wilding George
Cancer Chemotherapy and Pharmacology, Vol. 62, Iss. 4, 2008-09 ,pp. :
Experimental and Therapeutic Medicine, Vol. 2, Iss. 1, 2011-01 ,pp. :
A Phase I study of pazopanib in combination with gemcitabine in patients with advanced solid tumors
By Plummer Ruth Madi Ayman Jeffels Melinda Richly Heike Nokay Bahar Rubin Stephen Ball Howard Weller Steve Botbyl Jeffrey Gibson Diana Scheulen Max
Cancer Chemotherapy and Pharmacology, Vol. 71, Iss. 1, 2013-01 ,pp. :
Phase II trial of gemcitabine and S-1 for patients with advanced pancreatic cancer
By Song Hunho Han Boram Park Choong Kim Jong Jeon Jang Kim In-Gyu Kim Hyo Jung Joo Kim Jung Kwon Jung Jang Geundoo Kim Ho Kim Hyeong Choi Dae Zang Dae
Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 4, 2013-10 ,pp. :